Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(129 ratings | avg ★ 4.6)
App Store (129 ratings)
Last 28 days
Revenue
$2,403
AR
$28,836
MRR
$1,905
ARR
$22,860
Cash Flow Index
1.3x
Active Subscriptions
1,259
Active Trials
2
ARPAS
$1.91
Paid Subscriber Share (snapshot)
99.8%
Active Customers
769
New Customers
132
Subscription Penetration
163.7%
ARPU
$3.12
RPD
$3.12
ARPPU
$1.51
LTV
$5
MRR Growth (28d)
-15.4%
Revenue Growth (28d)
+64.9%
Subscriber Growth (28d)
-28.3%
All data is verified through RevenueCat. Last updated: Mar 16, 2026, 03:31:16 PM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$38,100
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗
Brainrot.mov
FOR SALELast 30 days rev
$9,645
MRR
$9,612
FitCal
FOR SALELast 30 days rev
$8,719
MRR
$7,440
-strive
FOR SALELast 30 days rev
$7,384
MRR
$10,588
Overlo
FOR SALELast 30 days rev
$1,390
MRR
$1,915
Push Up Time - App Blocker
FOR SALELast 30 days rev
$635
MRR
$668
CalBuddy
Last 30 days rev
$61,748
MRR
$24,210



